**Author details**

Manal M.A. Smail1,2, Chris F. Howarth1 , Jaipaul Singh3 \* and Abla Mohamed Ismail4

1 Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, United Arab Emirates

2 Fatima College for Health Sciences, United Arab Emirates

3 School of Forensic and Applied Sciences, University of Central Lancashire, Preston, Lancashire, England, United Kingdom

4 Corniche Hospital, United Arab Emirates

\*Address all correspondence to: jsingh3@uclan.ac.uk

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**105**

2014;**2**:1-17

*Inflammation and Diabetic Cardiomyopathy DOI: http://dx.doi.org/10.5772/intechopen.88149*

[1] Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham study. The Journal of the American Medical Association.

[10] Parashar K, Starling SK. Diabetes: History and traditional medication. Scientific Research. 2015;**4**(9):337-342

[11] Alcoholism, heart failure and diabetes (clinical conference). Medicina (Buenos Aires). 1993;**53**(3):239-247

phosphorylation in heart failure and arrhythmias: Protein kinase A-mediated hyperphosphorylation of the ryanodine receptor at serine 2808 does not alter cardiac contractility or cause heart failure and arrhythmias. Circulation Research. 2014;**114**(8):1320-1327

[12] Houser SR. Role of RyR2

[13] Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovascular Research.

[14] Houser SR, Marguiles KB. Is depressed myocyte contractility centrally involved in heart failure? Circulation Research.

and models in heart failure: The biomechanical model and beyond. Circulation. 2005;**111**(21):2837-3849

[15] Mann DL, Bristow MR. Mechanisms

[16] Pieske B, Maier LS, Piacentino V III, Weisser J, Hasenfuss G, Houser SR. Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation.

[17] Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P. Lowdose dobutamine responsiveness in idiopathic dilated cardiomyopathy: Relation to exercise capacity and clinical outcome. European Heart Journal.

[18] Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with

2016;**37**(2):279-289

2016;**92**(4):350-358

2002;**106**(4):447-453

2000;**21**(11):927-934

1979;**241**(19):2035-2038

[2] Roger VL. The heart failure epidemic. International Journal of Environmental Research and Public

Health. 2010;**7**(4):1807-1830

[3] Willerson JT, Ridker PM.

2006;**17**(1):4-12

Organization; 2011

2014;**129**(14):245-254

Health. 2009;**4**:383-392

2001;**414**(6865):782-787

Inflammation as a cardiovascular risk factor. Circulation. 2004;**109**(2):10

[4] Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network.

[5] Mendis S, Puska P, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. World Health

[6] Moran AE, Forouzanfar MH, Roth GA, Ezzati M, Flaxman A. The global burden of ischemic heart disease in 1990 and 2010: The global burden of disease 2010 study. Circulation.

[7] Belal AM. Nutrition-related chronic diseases epidemic in UAE: Can we stand to stop it? Sudanese Journal of Public

[8] Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature.

[9] Lockhart MM, Phelp AL, Van den Hoff MJB, Wessels A. The epicardium and the development of the atrioventricular junction in the murine heart. Developmental Biology.

**References**

*Inflammation and Diabetic Cardiomyopathy DOI: http://dx.doi.org/10.5772/intechopen.88149*
